These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 13582697)

  • 21. [Experience with an injectable preparation of Crataegus oxyacantha].
    ANDRE W
    Ther Ggw; 1957 May; 96(5):170-4. PubMed ID: 13442944
    [No Abstract]   [Full Text] [Related]  

  • 22. Interaction study between digoxin and a preparation of hawthorn (Crataegus oxyacantha).
    Tankanow R; Tamer HR; Streetman DS; Smith SG; Welton JL; Annesley T; Aaronson KD; Bleske BE
    J Clin Pharmacol; 2003 Jun; 43(6):637-42. PubMed ID: 12817526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Indications for Crataegus therapy].
    STORCH H
    Med Klin; 1954 Aug; 49(34):1331-4. PubMed ID: 13203011
    [No Abstract]   [Full Text] [Related]  

  • 24. High-performance liquid chromatography of flavonoids in Crataegus oxyacantha L. IV. Reversed-phase high-pressure liquid chromatography in flower, leaf and bud extractives of Crataegus oxyacantha L.
    Ficarra P; Ficarra R; de Pasquale A; Monforte MT; Calabrò ML
    Farmaco; 1990 Feb; 45(2):247-55. PubMed ID: 2133999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the content and stability of the constituents of mother tinctures and tinctures: the case of Crataegus oxyacantha L. and Hieracium pilosella L.
    Bilia AR; Eterno F; Bergonzi MC; Mazzi G; Vincieri FF
    J Pharm Biomed Anal; 2007 May; 44(1):70-8. PubMed ID: 17331690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [On heart therapy with reserpine and Crataegus].
    FESER A
    Med Klin; 1960 Jul; 55():1323-4. PubMed ID: 13822553
    [No Abstract]   [Full Text] [Related]  

  • 27. Anti-inflammatory, gastroprotective, free-radical-scavenging, and antimicrobial activities of hawthorn berries ethanol extract.
    Tadić VM; Dobrić S; Marković GM; Dordević SM; Arsić IA; Menković NR; Stević T
    J Agric Food Chem; 2008 Sep; 56(17):7700-9. PubMed ID: 18698794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Experiences with digitaloids in medicinal therapy of heart diseases].
    PILLEN D
    Med Klin; 1960 Sep; 55():1731-3. PubMed ID: 13735756
    [No Abstract]   [Full Text] [Related]  

  • 29. [The results of experimental and clinical studies. Cardio- and vasoprotective actions of standardized Crataegus extract].
    Koch E; Köhler S; Malek FA
    Pharm Unserer Zeit; 2005; 34(1):52-7. PubMed ID: 15700796
    [No Abstract]   [Full Text] [Related]  

  • 30. Myocardial protection by pretreatment with Crataegus oxyacantha: an assessment by means of the release of lactate dehydrogenase by the ischemic and reperfused Langendorff heart.
    Al Makdessi S; Sweidan H; Müllner S; Jacob R
    Arzneimittelforschung; 1996 Jan; 46(1):25-7. PubMed ID: 8821513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapeutic use of crataegus, a result of modern botanic pharmacology].
    MEYER E
    Munch Med Wochenschr; 1952 Jun; 94(24):1225-8. PubMed ID: 12982796
    [No Abstract]   [Full Text] [Related]  

  • 32. A reproductive screening test of hawthorn.
    Yao M; Ritchie HE; Brown-Woodman PD
    J Ethnopharmacol; 2008 Jun; 118(1):127-32. PubMed ID: 18485639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Oligomeric procyanidins from hawthorn extract as supplementary therapy in patients with left ventricle systolic dysfunction].
    Rechciński T; Kurpesa M
    Przegl Lek; 2005; 62(4):243-4. PubMed ID: 16229244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Animal experiments on the action of Crataegus oxyacantha L].
    HOLTZEM H
    Arzneimittelforschung; 1957 Feb; 7(2):140-1. PubMed ID: 13412597
    [No Abstract]   [Full Text] [Related]  

  • 35. [Absence of digitaloids in Crataegus oxyacantha. III. Constituents of hawthorn].
    NEU R
    Arzneimittelforschung; 1955 Oct; 5(10):604-9. PubMed ID: 13276296
    [No Abstract]   [Full Text] [Related]  

  • 36. [Electrocardiographic effects of a Crataegus oxyacantha extract].
    FOLDI M; SOLTI F; KOVACH AG; ISKUM N
    Arzneimittelforschung; 1959 Mar; 9(3):163-6. PubMed ID: 13651027
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical experiences on therapy of heart diseases with ex-parental Crataegus].
    JULIUS M
    Arztl Forsch; 1959 Jun; 13(6):276-92. PubMed ID: 13670054
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of Crataegus oxyacantha extract on the coronary blood flow in dogs].
    KOVACH AG; FOLDI M; FEDINA L
    Arzneimittelforschung; 1959 Jun; 9(6):378-9. PubMed ID: 13670869
    [No Abstract]   [Full Text] [Related]  

  • 39. Synergistic effect of tincture of Crataegus and Mangifera indica L. extract on hyperlipidemic and antioxidant status in atherogenic rats.
    Akila M; Devaraj H
    Vascul Pharmacol; 2008; 49(4-6):173-7. PubMed ID: 18755296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crataegus oxyacantha and heart failure.
    Gildor A
    Circulation; 1998 Nov; 98(19):2098. PubMed ID: 9808612
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.